Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS
Sneha Vivekanandhan(Saint Joseph's College), Debabrata Mukhopadhyay(Jacksonville College), Ramcharan Singh Angom(Mayo Clinic in Arizona), Yan W. Asmann(Mayo Clinic in Florida), Rosanna Upstill‐Goddard(University of Glasgow), Vijay Sagar Madamsetty(Jacksonville College), Enfeng Wang(Jacksonville College), Alexandre A. Pletnev(Dartmouth College), Shamit K. Dutta(WinnMed), Mark R. Spaller(Dartmouth College), Thomas R. Caulfield(Jacksonville College), David K. Chang(University of Glasgow)
Cited by 7
Related Papers
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
|Annals of Oncology|2020|478
A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer
|Science|2009|356
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
|Nature Communications|2020|245
In vivo gene delivery mediated by non-viral vectors for cancer therapy
|Journal of Controlled Release|2020|240
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
|Frontiers in Pharmacology|2019|210